DeepTech Investor Summit

InvestmentUpdated on 21 January 2026

Pre-Seed Oversubscription

CEO & Co-Founder at Immitra Bio

Zürich, Switzerland

About

We are aiming to close our pre-seed round in Q1 to reach key inflection points and extend our runway to 24 months. CHF 1.2 M is already committed, exceeding our CHF 1 M target, which finances us through animal proof-of-concept studies. We are now engaging with a select group of investors for an oversubscription of CHF 2M + to pursue additional stretch goals and further extend our runway.

Stage

  • Pre-Seed

Applies to

  • Bio Tech

Similar opportunities